PHARMASIMPLE
Voor PHARMASIMPLE is een faillissementsprocedure geopend volgens publicaties in het Belgisch Staatsblad. De jaarrekening over 2021 toont een eigen vermogen van €4,14M en een nettoresultaat van €-8,94M.
| Eigen vermogen | €4,14M |
| Netto resultaat | €-8,94M |
| Werknemers (VTE) | 57,9 |
| Beter dan sector | 47% |
Kwetsbaar profiel, let vooral op gezondheid.
Alle 5 assen zijn berekend uit gegevens die Checked heeft ingelezen.
Faillissement geopend
Er loopt al een faillissementsprocedure, een kans-score is dan niet meer zinvol. Bekijk de insolventietijdlijn voor de stand van de procedure.
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je vanaf Kantoor S.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | 22,8% | 25,2% | |
| Nettoresultaat | €-8,94M | €17k | |
| Eigen vermogen | €4,14M | €133k | |
| Personeelskosten | €3,35M | €151k | |
| Werknemers (VTE) | 57,9 | 5,5 |
| Boekjaar | 2021 |
|---|---|
| Neerlegging | volledig |
| Omzet | €29,90M |
| EBITDA | €-7,64M |
| Nettoresultaat | €-8,94M |
| Cashflow | €-8,02M |
| Personeelskosten | €3,35M |
| Belastingen op het resultaat | €1k |
| Dividenden | - |
| Totaal activa | €18,19M |
| Eigen vermogen | €4,14M |
| Schulden | €14,05M |
| waarvan ≤ 1 jaar | €8,49M |
| waarvan > 1 jaar | €5,52M |
| Werkkapitaal | €1,10M |
| Werknemers (VTE) | 57,9 |
| 2021 | |
|---|---|
| Current ratio | 1,13 |
| Quick ratio | 0,76 |
| Werkkapitaalratio | 6,1% |
| Solvabiliteit | 22,8% |
| Debt / equity | 3,39 |
| Langetermijnschuldgraad | 1,33 |
| Interest coverage | -22,52 |
| Bruto rentabiliteit | 11,0% |
| Netto rentabiliteit | -29,9% |
| ROA | -49,1% |
| ROE | -215,6% |
| EBITDA-marge | -25,6% |
| Klantenkrediet (DSO) | 56d |
| Leverancierskrediet (DPO) | 54d |
| Voorraadrotatie | 8,46 |
| Voorraaddagen (DSI) | 43d |
| Post | Code | 2021 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €18,19M |
| Vaste activa | 21/28 | €8,44M |
| Oprichtingskosten | 20 | €161k |
| Immateriële vaste activa | 21 | €1,05M |
| Materiële vaste activa | 22/27 | €268k |
| Financiële vaste activa | 28 | €7,13M |
| Vlottende activa | 29/58 | €9,59M |
| Voorraden en bestellingen in uitvoering | 3 | €3,15M |
| Vorderingen op ten hoogste één jaar | 40/41 | €5,22M |
| Liquide middelen | 54/58 | €1,12M |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €18,19M |
| Eigen vermogen | 10/15 | €4,14M |
| Inbreng / kapitaal | 10/11 | €15,24M |
| Overgedragen winst (verlies) | 14 | €-11,10M |
| Schulden | 17/49 | €14,05M |
| Schulden op meer dan één jaar | 17 | €5,52M |
| Schulden op ten hoogste één jaar | 42/48 | €8,49M |
| Handelsschulden op ten hoogste één jaar | 44 | €3,91M |
| Resultatenrekening | ||
| Omzet | 70 | €29,90M |
| Bedrijfsresultaat | 9901 | €-8,55M |
| Financiële opbrengsten | 75 | €95 |
| Financiële kosten | 65 | €383k |
| Resultaat vóór belasting | 9903 | €-8,94M |
| Belastingen op het resultaat | 67/77 | €1k |
| Resultaat van het boekjaar | 9904 | €-8,94M |
| Te bestemmen resultaat | 9905 | €-8,94M |
-
Stéphane BruxAdministrateur provisoireStaatsblad-akte 23078509 (16-06-2023)Actief16-06-2023 → heden
-
Jean-Paul MichielsenBestuurderStaatsblad-akte 23028206 (27-02-2023)Actief27-02-2023 → heden
-
Eric van der HaegenBestuurderStaatsblad-akte 22372457 (14-11-2022)Actief14-11-2022 → heden
-
CHAMAGABestuurderStaatsblad-akte 22372457 (14-11-2022)Actief12-10-2022 → heden
2 gebeurtenissen
- 14-11-2022 Benoemd· Bestuurder
- 12-10-2022 Benoemd· Bestuurder
-
Michael WillemsBestuurderStaatsblad-akte 22105127 (02-09-2022)Actief02-09-2022 → heden
Historisch, niet recent bevestigd (6)
-
AM CONSULTANCYBestuurderStaatsblad-akte 20054765 (05-05-2020)Niet recent bevestigdlaatst bevestigd in akte van 2020
2 gebeurtenissen
- 05-05-2020 Benoemd· Bestuurder
- 28-10-2016 Benoemd· Bestuurder
-
Annabelle THIRYGedelegeerd bestuurderStaatsblad-akte 15116920 (13-08-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
-
la Compagnie du CAPBestuurderStaatsblad-akte 15116920 (13-08-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
-
MFI- MARKETING FINANCE INTERNATIONALBestuurderStaatsblad-akte 15116920 (13-08-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
2 gebeurtenissen
- 05-05-2020 Ontslagen· Bestuurder
- 13-08-2015 Benoemd· Bestuurder
-
Michaël WILLEMSPrésident du conseil d'administrationStaatsblad-akte 15116920 (13-08-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
-
Stéphane MOITYBestuurderStaatsblad-akte 15114973 (10-08-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
Voormalige bestuurders (6)
-
Didier PêtreBestuurderStaatsblad-akte 22017588 (09-02-2022)Voormalig09-02-2022 → 14-11-2022
3 gebeurtenissen
- 14-11-2022 Ontslagen· Bestuurder
- 12-10-2022 Ontslagen· Bestuurder
- 09-02-2022 Benoemd· Bestuurder
-
Harold LanoyBestuurderStaatsblad-akte 22372457 (14-11-2022)Voormalig- → 14-11-2022
-
Harold LannoyBestuurderStaatsblad-akte 22017588 (09-02-2022)Voormalig09-02-2022 → 12-10-2022
2 gebeurtenissen
- 12-10-2022 Ontslagen· Bestuurder
- 09-02-2022 Benoemd· Bestuurder
-
MG CONSULTINGBestuurderStaatsblad-akte 20054765 (05-05-2020)Voormalig05-05-2020 → 09-02-2022
2 gebeurtenissen
- 09-02-2022 Ontslagen· Bestuurder
- 05-05-2020 Benoemd· Bestuurder
-
SAMANDA SARechtspersoonBestuurderStaatsblad-akte 21137724 (23-11-2021)Voormalig- → 23-11-2021
-
THIRY Annabelle Muriel Marc MarieBestuurderStaatsblad-akte 16149767 (28-10-2016)Voormalig- → 28-10-2016
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| Julie DelforgeActief Commissaire |
- | 09-02-2022 → heden |
| Rol | Naam | Periode | Bron |
|---|---|---|---|
| Curator | ISABELLE BRONKAERT CHAUSSEE DE THUIN 164,
6032 MONT-SUR-MARCHIENNE |
19-06-2023 → heden | Belgisch Staatsblad |
| Curator | PIERRE-EMMANUEL CORNIL RUE DE GOZEE, 137,
6110 MONTIGNY-LE-TILLEUL- .
Date provisoire de cessation de paiement : 19/06/2023 |
19-06-2023 → heden | Belgisch Staatsblad |
| NACE primair | Overige niet-gespecialiseerde detailhandel(47120) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 27-04-2012 |
| Status | Actief |
| Postcode | 7180 |
| Eerste BS-signaal | 23-06-2023 |
| Laatste BS-signaal | 23-06-2023 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 52063E0154/00D000 | Wallonië | 5,1 ha | 1 · 1.605 m² | 7,8 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
16-06-2023 Stéphane Brux benoemd tot administrateur provisoire
- Stéphane Brux, Administrateur provisoire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur provisoire",
"person": {
"rrn": null,
"name": "St\u00E9phane Brux",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}08-05-2023 Kapitaalverhoging van €100.000 tot €25.341.764,20
- €25.241.764,20 → €25.341.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 25341764.2,
"delta_eur": 100000.0,
"before_eur": 25241764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}12-04-2023 Kapitaalverhoging van €100.000 tot €25.191.764,20
- €25.091.764,20 → €25.191.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 25191764.2,
"delta_eur": 100000.0,
"before_eur": 25091764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}27-03-2023 Kapitaalverhoging van €150.000 tot €24.941.764,20
- €24.791.764,20 → €24.941.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 24941764.2,
"delta_eur": 150000.0,
"before_eur": 24791764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}02-03-2023 Kapitaalverhoging van €50.000 tot €24.216.764,20
- €24.166.764,20 → €24.216.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 24216764.2,
"delta_eur": 50000.0,
"before_eur": 24166764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}27-02-2023 Jean-Paul Michielsen benoemd tot bestuurder
- Jean-Paul Michielsen, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Paul Michielsen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "Pharmasimple"
}
}19-01-2023 Kapitaalverhoging van €500.000 tot €24.016.764,20
- €23.516.764,20 → €24.016.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 24016764.2,
"delta_eur": 500000.0,
"before_eur": 23516764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}10-01-2023 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-01-10",
"filing_date": "2023-01-06",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2022-12-27",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": null,
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": null,
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0845.603.735",
"name": "PHARMASIMPLE",
"role": "other",
"address": "Boulevard Millenium(H-G) 11, 7110 La Louvi\u00E8re",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.00002,
"legal_articles": [
"12:7",
"12:50"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": "1 nouvelle action pour 50.000 actions existantes",
"new_shares_issued_n": 152947,
"real_estate_included": false,
"patrimony_description": "Le regroupement concerne l\u0027ensemble du capital social de la soci\u00E9t\u00E9. Les actions existantes ont \u00E9t\u00E9 annul\u00E9es et remplac\u00E9es par un nombre r\u00E9duit d\u0027actions nouvelles, sans modification du montant du capital.",
"equity_transferred_eur": 23516764.2,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le 27 d\u00E9cembre 2022, le notaire Peter VAN MELKEBEKE a constat\u00E9 le regroupement d\u0027actions de la soci\u00E9t\u00E9 anonyme PHARMASIMPLE, r\u00E9sultant d\u0027une d\u00E9cision du conseil d\u0027administration. Ce regroupement a r\u00E9duit le nombre d\u0027actions en circulation de mani\u00E8re proportionnelle, passant de plus de 7,5 millions \u00E0 152 947 actions nouvelles, sans modification du capital social. Les anciennes actions ont \u00E9t\u00E9 annul\u00E9es. Les statuts ont \u00E9t\u00E9 modifi\u00E9s pour refl\u00E9ter cette op\u00E9ration.",
"co_filed_documents": [
"une exp\u00E9dition de l\u2019acte",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}20-12-2022 Kapitaalverhoging van €75.000 tot €23.516.764,20
- €23.441.764,20 → €23.516.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 23516764.2,
"delta_eur": 75000.0,
"before_eur": 23441764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}14-11-2022 2 bestuurders benoemd, 2 ontslagnemend
- Eric van der Haegen, Bestuurder
- CHAMAGA, Bestuurder
- Harold Lanoy, Bestuurder
- Didier Pêtre, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Harold Lanoy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Didier P\u00EAtre",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric van der Haegen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "CHAMAGA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}08-11-2022 Kapitaalverhoging van €150.000 tot €22.841.764,20
- €22.691.764,20 → €22.841.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 22841764.2,
"delta_eur": 150000.0,
"before_eur": 22691764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}13-10-2022 Kapitaalverhoging van €100.000 tot €22.541.764,20
- €22.441.764,20 → €22.541.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 22541764.2,
"delta_eur": 100000.0,
"before_eur": 22441764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}12-10-2022 1 bestuurder benoemd, 2 ontslagnemend
- Chamaga, Bestuurder
- Harold Lannoy, Bestuurder
- Didier Pêtre, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Harold Lannoy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Didier P\u00EAtre",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Chamaga",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "Pharmasimple"
}
}12-09-2022 Kapitaalverhoging van €200.000 tot €21.791.764,20
- €21.591.764,20 → €21.791.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 21791764.2,
"delta_eur": 200000.0,
"before_eur": 21591764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}02-09-2022 Michael Willems benoemd tot bestuurder
- Michael Willems, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael Willems",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}26-08-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}16-08-2022 Kapitaalverhoging van €150.000 tot €21.241.764,20
- €21.091.764,20 → €21.241.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 21241764.2,
"delta_eur": 150000.0,
"before_eur": 21091764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}28-06-2022 Kapitaalverhoging van €300.000 tot €19.791.764,20
- €19.491.764,20 → €19.791.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19791764.2,
"delta_eur": 300000.0,
"before_eur": 19491764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}03-06-2022 Kapitaalverhoging van €300.000 tot €18.891.764,20
- €18.591.764,20 → €18.891.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 18891764.2,
"delta_eur": 300000.0,
"before_eur": 18591764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}18-05-2022 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-05-18",
"filing_date": "2022-05-16",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2022-05-12",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0845.603.735",
"name": "PHARMASIMPLE SA",
"role": "contributor",
"address": "Boulevard Millenium (H-G) 11, 7110 La Louvi\u00E8re",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "Investisseur",
"role": "recipient",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:179",
"7:180",
"7:191",
"7:193",
"7:197"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "L\u0027apport en nature concerne des cr\u00E9ances d\u00E9tenues par l\u0027Investisseur \u00E0 l\u0027encontre de la soci\u00E9t\u00E9 Pharmasimple SA. Ces cr\u00E9ances sont transf\u00E9r\u00E9es en contrepartie de 4.000 obligations convertibles.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le conseil d\u0027administration de Pharmasimple SA a d\u00E9cid\u00E9 d\u0027\u00E9mettre 44.000 obligations convertibles d\u0027une valeur nominale de 5.000 EUR chacune, dont 40.000 en num\u00E9raire et 4.000 en apport en nature sous forme de cr\u00E9ances d\u00E9tenues par l\u0027Investisseur. Le droit de pr\u00E9f\u00E9rence des actionnaires a \u00E9t\u00E9 supprim\u00E9. L\u0027augmentation de capital interviendra conditionnellement \u00E0 la souscription et conversion des obligations. Le commissaire a confirm\u00E9 que les donn\u00E9es financi\u00E8res et l\u0027\u00E9valuation de l\u0027apport sont fid\u00E8les et suffisantes.",
"co_filed_documents": [
"proc\u00E8s-verbal",
"liste de pr\u00E9sence",
"procuration",
"rapport du conseil d\u0027administration",
"rapport du commissaire"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}28-03-2022 Kapitaalverhoging van €0 tot €18.491.764,20
- €18.491.764,20 → €18.491.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 18491764.2,
"delta_eur": 0.0,
"before_eur": 18491764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}10-03-2022 Kapitaalverhoging van €500.000 tot €16.491.764,20
- €15.991.764,20 → €16.491.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 16491764.2,
"delta_eur": 500000.0,
"before_eur": 15991764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}16-02-2022 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}16-02-2022 Kapitaalverhoging van €500.000 tot €15.991.764,20
- €15.491.764,20 → €15.991.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 15991764.2,
"delta_eur": 500000.0,
"before_eur": 15491764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}09-02-2022 3 bestuurders benoemd, 1 ontslagnemend
- Julie Delforge, Commissaire
- Didier Pêtre, Bestuurder
- Harold Lannoy, Bestuurder
- MG Consulting, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MG Consulting",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Didier P\u00EAtre",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Harold Lannoy",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}21-01-2022 Kapitaalverhoging van €500.000 tot €13.741.764,20
- €13.241.764,20 → €13.741.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 13741764.2,
"delta_eur": 500000.0,
"before_eur": 13241764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}08-12-2021 Kapitaalverhoging van €0 tot €11.991.764,20
- €11.991.764,20 → €11.991.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 11991764.2,
"delta_eur": 0.0,
"before_eur": 11991764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}23-11-2021 SAMANDA SA neemt ontslag als bestuurder
- SAMANDA SA, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SAMANDA SA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}22-11-2021 Kapitaalverhoging van €75.000 tot €8.066.764,20
- €7.991.764,20 → €8.066.764,20
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8066764.2,
"delta_eur": 75000.0,
"before_eur": 7991764.2,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
}
}19-10-2021 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0845.603.735",
"name_full": "PHARMASIMPLE"
},
"legal_form_change": {
"new": "",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | PHARMASIMPLE |